Recent News

By Category: Countermeasures

U.S. Begins Receiving Controversial Smallpox Medicine

(GlobalSecurityNewswire) A New York biotechnology firm last week delivered to the U.S. government the initial batch of a new smallpox treatment in a $463 million order that has prompted cost concerns among some issue experts, the New York Times reported on Tuesday. SIGA Technologies in 2011 received a single-bid contract to manufacture 1.7 million doses  Read More »

Chicken pox vaccine saving children’s lives

(University of Adelaide) The widespread introduction of a chicken pox vaccine in Australia in 2006 has prevented thousands of children from being hospitalized with severe chicken pox and saved lives, according to new research.

Wary of Attack With Smallpox, US Buys Up a Costly Drug – New York Times

Wary of Attack With Smallpox, US Buys Up a Costly DrugNew York TimesThe United States government is buying enough of a new smallpox medicine to treat two million people in the event of a bioterrorism attack, and took delivery of the first shipment of it last week. But the purchase has set off a debate  Read More »

U.S. Funds Biodefense Drug Development

(GlobalSecurityNewswire) The Obama administration has announced plans to provide $20 million in the coming budget year for a grant initiative aimed at promoting production of new vaccines and medicines for use after a deliberate or natural disease outbreak.

Publicly funded H5N1 vaccine available for high-risk people

(ChinaPost) A publicly funded H5N1 flu vaccine is available until Aug. 31 for people over 18 years old and at high risk, the Centers for Disease Control said yesterday.